← Evidence map

ReviewTherapeutics and clinical risk management2022

Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First.

Anagha Deshpande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35770040